Autobahn Labs is a biotechnology company that accelerates the development of novel therapeutics. Founded in 2016, their team of scientists, investors, and entrepreneurs focus on early-stage ventures, aiming to create impactful treatments that change the lives of patients.
Deal activity and portfolio updates would appear here
Connect your data source to see recent transactions